Ulrich Ebert
21Patents
6h-index
43Co-inventors
65Inventor score
Filing activity: Jun 16, 2004 → Jul 27, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8323651B2 | Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof | Emerging Cross-Sectional Technologies | 28 | Active |
| US7488733B2 | 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors | Chemistry; Metallurgy | 23 | Expired |
| US8263558B2 | Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins | Human Necessities | 20 | Active |
| US8987419B2 | Amyloid-beta binding proteins | Chemistry; Metallurgy | 14 | Active |
| US8691224B2 | Anti-Aβ globulomer 5F7 antibodies | Physics | 13 | Active |
| US9394360B2 | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies | Physics | 6 | Active |
| US8497072B2 | Amyloid-beta globulomer antibodies | Physics | 6 | Active |
| US9062101B2 | Amyloid-beta binding proteins | Chemistry; Metallurgy | 5 | Active |
| US8455626B2 | Aβ conformer selective anti-aβ globulomer monoclonal antibodies | Physics | 4 | Active |
| US9359430B2 | Abeta conformer selective anti-Abeta globulomer monoclonal antibodies | Physics | 4 | Active |
| US9291621B2 | AGER-peptides and use thereof | Physics | 2 | Active |
| US10323084B2 | Monoclonal antibodies against amyloid beta protein and uses thereof | Physics | 2 | Active |
| US8895004B2 | Method for the treatment of amyloidoses | Human Necessities | 2 | Active |
| US10047121B2 | Amyloid-beta binding proteins | Chemistry; Metallurgy | 1 | Active |
| US9951125B2 | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies | Physics | 1 | Active |
| US10538581B2 | Anti-Aβ globulomer 4D10 antibodies | Physics | 1 | Active |
| US9822171B2 | Amyloid-beta binding proteins | Chemistry; Metallurgy | 0 | Active |
| US9540432B2 | Anti-Aβ globulomer 7C6 antibodies | Physics | 0 | Active |
| US9394363B2 | Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10208109B2 | Monoclonal antibodies against amyloid beta protein and uses thereof | Physics | 0 | Active |
| US8877190B2 | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.